Annual advances in pediatric rheumatic and immunologic diseases
10.3760/cma.j.cn141217-20250127-00030
- VernacularTitle:儿童风湿免疫性疾病年度进展
- Author:
Fengqiao GAO
1
;
Junmei ZHANG
1
;
Caifeng LI
1
Author Information
1. 国家儿童医学中心（北京）首都医科大学附属北京儿童医院风湿科，北京 100045
- Publication Type:Journal Article
- Keywords:
Pediatrics;
Progress;
Juvenile idiopathic arthritis;
Lupus erythematosus, systemic;
Autoinflammatory diseases
- From:
Chinese Journal of Rheumatology
2025;29(6):441-445
- CountryChina
- Language:Chinese
-
Abstract:
In 2024, significant advancements have been achieved in the field of pediatric rheumatic and immunological diseases, spanning key conditions such as juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE), and autoinflammatory diseases (AIDs). These developments encompass the indepth elucidation of disease pathogenesis, the expanded application of biomarkers, continuous updates to clinical practice guidelines, and the development of novel targeted therapies. These advances have markedly enhanced the precision and effectiveness of clinical diagnosis and treatment while laying a solid foundation for improving long-term patient outcomes. This article highlights the key research breakthroughs and significant progress in pediatric rheumatic and immunological diseases in 2024, aiming to advance clinical understanding, promote early recognition, and enable accurate diagnosis to optimize outcomes for affected children.
